JP7443696B2 - Polyol composition for molding flexible polyurethane foam - Google Patents
Polyol composition for molding flexible polyurethane foam Download PDFInfo
- Publication number
- JP7443696B2 JP7443696B2 JP2019156884A JP2019156884A JP7443696B2 JP 7443696 B2 JP7443696 B2 JP 7443696B2 JP 2019156884 A JP2019156884 A JP 2019156884A JP 2019156884 A JP2019156884 A JP 2019156884A JP 7443696 B2 JP7443696 B2 JP 7443696B2
- Authority
- JP
- Japan
- Prior art keywords
- polyurethane foam
- flexible polyurethane
- polyol
- molding
- foam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920005862 polyol Polymers 0.000 title claims description 111
- 150000003077 polyols Chemical class 0.000 title claims description 109
- 229920005830 Polyurethane Foam Polymers 0.000 title claims description 85
- 239000011496 polyurethane foam Substances 0.000 title claims description 85
- 239000000203 mixture Substances 0.000 title claims description 61
- 238000000465 moulding Methods 0.000 title claims description 33
- 239000006260 foam Substances 0.000 claims description 67
- 150000001720 carbohydrates Chemical class 0.000 claims description 58
- 238000005187 foaming Methods 0.000 claims description 40
- 235000014633 carbohydrates Nutrition 0.000 claims description 34
- 239000003431 cross linking reagent Substances 0.000 claims description 33
- 239000003054 catalyst Substances 0.000 claims description 32
- -1 alicyclic glycols Chemical class 0.000 claims description 26
- 150000002772 monosaccharides Chemical class 0.000 claims description 24
- 238000007906 compression Methods 0.000 claims description 22
- 230000006835 compression Effects 0.000 claims description 22
- 229920001228 polyisocyanate Polymers 0.000 claims description 20
- 239000005056 polyisocyanate Substances 0.000 claims description 20
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 17
- 238000010097 foam moulding Methods 0.000 claims description 14
- 235000000346 sugar Nutrition 0.000 claims description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 13
- 239000003381 stabilizer Substances 0.000 claims description 13
- 125000006353 oxyethylene group Chemical group 0.000 claims description 11
- 239000004604 Blowing Agent Substances 0.000 claims description 10
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 10
- 229920000570 polyether Polymers 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 229920002635 polyurethane Polymers 0.000 claims description 7
- 239000004814 polyurethane Substances 0.000 claims description 7
- 125000004122 cyclic group Chemical group 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 5
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- LFSYUSUFCBOHGU-UHFFFAOYSA-N 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=CC=C1N=C=O LFSYUSUFCBOHGU-UHFFFAOYSA-N 0.000 claims description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 3
- GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- XLYOFNOQVPJJNP-DYCDLGHISA-N deuterium hydrogen oxide Chemical compound [2H]O XLYOFNOQVPJJNP-DYCDLGHISA-N 0.000 claims 4
- 238000009826 distribution Methods 0.000 description 23
- 229920001542 oligosaccharide Polymers 0.000 description 21
- 239000010410 layer Substances 0.000 description 20
- 238000002156 mixing Methods 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 150000002482 oligosaccharides Chemical class 0.000 description 13
- 230000007423 decrease Effects 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- 125000000524 functional group Chemical group 0.000 description 11
- 239000012948 isocyanate Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000004202 carbamide Substances 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 150000002513 isocyanates Chemical class 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000002016 disaccharides Chemical group 0.000 description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 6
- 229940077731 carbohydrate nutrients Drugs 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 150000004043 trisaccharides Chemical class 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000013518 molded foam Substances 0.000 description 5
- 229920005906 polyester polyol Polymers 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- IISBACLAFKSPIT-UHFFFAOYSA-N Bisphenol A Natural products C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 235000019534 high fructose corn syrup Nutrition 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001323 aldoses Chemical class 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000006082 mold release agent Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- 229920000265 Polyparaphenylene Polymers 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- LUEWUZLMQUOBSB-ZLBHSGTGSA-N alpha-maltotetraose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-ZLBHSGTGSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000004872 foam stabilizing agent Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 150000003538 tetroses Chemical class 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- DFKPJBWUFOESDV-NGZVDTABSA-N (2S,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@@H](OC[C@@H]3[C@H]([C@H](O)[C@@H](O)[C@@H](O)O3)O)O2)O)O1 DFKPJBWUFOESDV-NGZVDTABSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- KOJXXRFVSGWKCI-UHFFFAOYSA-N 1,2-dimethylimidazole Chemical compound CC1=NC=[C]N1C KOJXXRFVSGWKCI-UHFFFAOYSA-N 0.000 description 1
- ZEPAXLPHESYSJU-UHFFFAOYSA-N 2,3,4,5,6,7,8-heptahydroxyoctanal Chemical compound OCC(O)C(O)C(O)C(O)C(O)C(O)C=O ZEPAXLPHESYSJU-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- GTEXIOINCJRBIO-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]-n,n-dimethylethanamine Chemical compound CN(C)CCOCCN(C)C GTEXIOINCJRBIO-UHFFFAOYSA-N 0.000 description 1
- WTPYFJNYAMXZJG-UHFFFAOYSA-N 2-[4-(2-hydroxyethoxy)phenoxy]ethanol Chemical compound OCCOC1=CC=C(OCCO)C=C1 WTPYFJNYAMXZJG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- CZMRCDWAGMRECN-FBXJDJJESA-N D-sucrose Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@]1(CO)O[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O1 CZMRCDWAGMRECN-FBXJDJJESA-N 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-OBAJZVCXSA-N Gentianose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@H](O)[C@@H](CO)O2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-OBAJZVCXSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- NIBVDXPSJBYJFT-VBBCUDLLSA-N Planteose Natural products O(C[C@@H]1[C@H](O)[C@@H](O)[C@@](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)(CO)O1)[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1 NIBVDXPSJBYJFT-VBBCUDLLSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002323 Silicone foam Polymers 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- LNRUEZIDUKQGRH-UHFFFAOYSA-N Umbelliferose Natural products OC1C(O)C(CO)OC1(CO)OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 LNRUEZIDUKQGRH-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- ORLQHILJRHBSAY-UHFFFAOYSA-N [1-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1(CO)CCCCC1 ORLQHILJRHBSAY-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- FBJQEBRMDXPWNX-SMGIPPFUSA-N alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-SMGIPPFUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-NCFXGAEVSA-N beta,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-NCFXGAEVSA-N 0.000 description 1
- QYNRIDLOTGRNML-XJBKZTKUSA-N beta-D-Xylp-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 QYNRIDLOTGRNML-XJBKZTKUSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012792 core layer Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 150000008266 deoxy sugars Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 239000012972 dimethylethanolamine Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- PVAONLSZTBKFKM-UHFFFAOYSA-N diphenylmethanediol Chemical compound C=1C=CC=CC=1C(O)(O)C1=CC=CC=C1 PVAONLSZTBKFKM-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 150000002170 ethers Chemical group 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- MUPFEKGTMRGPLJ-WSCXOGSTSA-N gentianose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-WSCXOGSTSA-N 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 150000002386 heptoses Chemical class 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000002453 idose derivatives Chemical class 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- PIBXBCFBUUZPRF-UHFFFAOYSA-N isocyclomaltohexaose Natural products OCC1OC2OCC3OC(OC4C(O)C(O)C(OC4CO)OC5C(O)C(O)C(OC5CO)OC6C(O)C(O)C(OC6CO)OC7C(O)C(O)C(OC7CO)OC1C(O)C2O)C(O)C(O)C3O PIBXBCFBUUZPRF-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- QIGJYVCQYDKYDW-LCOYTZNXSA-N laminarabiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-LCOYTZNXSA-N 0.000 description 1
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- TXXWBTOATXBWDR-UHFFFAOYSA-N n,n,n',n'-tetramethylhexane-1,6-diamine Chemical compound CN(C)CCCCCCN(C)C TXXWBTOATXBWDR-UHFFFAOYSA-N 0.000 description 1
- QIGJYVCQYDKYDW-NSYYTRPSSA-N nigerose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-NSYYTRPSSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- UKODFQOELJFMII-UHFFFAOYSA-N pentamethyldiethylenetriamine Chemical compound CN(C)CCN(C)CCN(C)C UKODFQOELJFMII-UHFFFAOYSA-N 0.000 description 1
- NIBVDXPSJBYJFT-ZQSKZDJDSA-N planteose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 NIBVDXPSJBYJFT-ZQSKZDJDSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000909 polytetrahydrofuran Polymers 0.000 description 1
- QYNRIDLOTGRNML-UHFFFAOYSA-N primeverose Natural products OC1C(O)C(O)COC1OCC1C(O)C(O)C(O)C(O)O1 QYNRIDLOTGRNML-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000013514 silicone foam Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- XNBZPOHDTUWNMW-QVCHUJKCSA-N solatriose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@@H](CO)OC1O XNBZPOHDTUWNMW-QVCHUJKCSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- HIWPGCMGAMJNRG-RTPHMHGBSA-N sophorose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-RTPHMHGBSA-N 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 150000003641 trioses Chemical class 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- LNRUEZIDUKQGRH-YZUCMPLFSA-N umbelliferose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 LNRUEZIDUKQGRH-YZUCMPLFSA-N 0.000 description 1
- AVWRKZWQTYIKIY-UHFFFAOYSA-N urea-1-carboxylic acid Chemical compound NC(=O)NC(O)=O AVWRKZWQTYIKIY-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Description
本発明は、軟質ポリウレタンフォーム成型用ポリオール組成物及び該組成物を用いた軟質ポリウレタンフォームに関する。 The present invention relates to a polyol composition for molding flexible polyurethane foam and a flexible polyurethane foam using the composition.
軟質ポリウレタンフォームは生活用品、自動車用材料、衣料、スポーツ・レジャー用品、医療用材料、土木建築材料等、広範囲に使用されている。このような用途分野の中でも特に自動車用シートや車椅子などのクッション材用途においては従来から求められる機能に加え、着座する際の初期圧縮時に感じる硬さや、カーブ走行時に乗員の腰部や臀部等が横方向に傾くことで感じるぐらつき感を低減する事が求められている。これらの課題を達成するためには、軟質ポリウレタンフォームの初期圧縮時には硬度が発現しにくく、かつ高圧縮時には硬度が発現しやすい硬度分布とする事で着座姿勢をより安定保持する事が必要である。 Flexible polyurethane foam is used in a wide range of applications, including household goods, automobile materials, clothing, sports and leisure goods, medical materials, and civil engineering and construction materials. Among these application fields, in addition to the functions traditionally required for cushioning materials such as automobile seats and wheelchairs, there is also the need for stiffness during the initial compression when sitting, and for the lateral movement of the lower back and buttocks of occupants when driving around curves. There is a need to reduce the feeling of wobbling caused by tilting in one direction. In order to achieve these goals, it is necessary to maintain a more stable sitting posture by creating a hardness distribution that makes it difficult for soft polyurethane foam to develop hardness during initial compression, but is more likely to develop hardness during high compression. .
この硬度分布を発現させる手段として、従来種々の取り組みがなされている。例えば、高弾性のポリウレタンフォームを上層(座面側)に配置し、粘弾性フォームを下層(底面側)に配置した積層構造のシートクッション構造が開示されている(特許文献1)。これによれば、下層側粘弾性フォームが上層側高弾性フォームを介して軟らかいフィット感を乗員に間接的に与え、上層高弾性フォームがクッション感を乗員に直接与える。これらの相乗的作用により座り心地の改善が図られるが、部品点数の増加や、接着等により発泡体を一体化する工程が多くなるなどの問題が生じる。また、部位別にシートの密度を変える事で硬度分布を発現させる技術が開示されている(特許文献2)。しかしながら、密度変化で硬度を調整した場合、硬度を上げるためには密度を上げなければならず、コストの増加につながる。また、部位別に成型を行う必要があり、工数が増えるという問題がある。また、ポリオール組成物中に含有される架橋剤成分の有する主な重合性基(反応性基)がエチレンオキサイド基であること、グリセリンを含有させること、及び発泡セルの形状を制御する事で、同一密度でも硬度分布を発現させる技術が開示されている(特許文献3)。しかしながら、これらの要因だけでは着座時に感じる初期圧縮時の硬さを低減し、且つぐらつき感を抑制する硬度分布の発現は不十分である。 Various efforts have been made in the past as means to develop this hardness distribution. For example, a seat cushion structure with a laminated structure in which highly elastic polyurethane foam is arranged in the upper layer (seat side) and viscoelastic foam is arranged in the lower layer (bottom side) is disclosed (Patent Document 1). According to this, the lower layer side viscoelastic foam indirectly provides a soft fit feeling to the occupant via the upper layer side high elastic foam, and the upper layer high elastic foam directly provides a cushioned feeling to the occupant. Although these synergistic effects improve seating comfort, problems arise, such as an increase in the number of parts and an increase in the number of steps for integrating the foams by adhesion or the like. Further, a technique has been disclosed in which hardness distribution is expressed by changing the density of the sheet for each region (Patent Document 2). However, when the hardness is adjusted by changing the density, the density must be increased in order to increase the hardness, which leads to an increase in cost. Additionally, it is necessary to mold each part separately, which increases the number of man-hours. In addition, the main polymerizable group (reactive group) of the crosslinking agent component contained in the polyol composition is an ethylene oxide group, the inclusion of glycerin, and the control of the shape of the foam cells. A technique for developing hardness distribution even at the same density has been disclosed (Patent Document 3). However, these factors alone are insufficient to reduce the initial compression hardness felt when sitting and to develop a hardness distribution that suppresses the feeling of wobbling.
本発明は上記背景技術に鑑みてなされたものであり、クッション材として用いたときの座り心地が良好な硬度分布を有する軟質ポリウレタンフォーム成型用ポリオール組成物及び該組成物を用いた軟質ポリウレタンフォームを提供することを目的とする。 The present invention has been made in view of the above-mentioned background art, and provides a polyol composition for molding a flexible polyurethane foam that has a hardness distribution that provides good seating comfort when used as a cushioning material, and a flexible polyurethane foam using the composition. The purpose is to provide.
すなわち、本発明は以下に示す実施形態を含むものである。 That is, the present invention includes the embodiments shown below.
(1)ポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、及び架橋剤(E)を含む軟質ポリウレタンフォーム成型用ポリオール組成物であって、架橋剤(E)として糖質(E-1)を含有し、該糖質(E-1)の添加量がポリオール成分(A)に対して0.1~5質量%であることを特徴とする、軟質ポリウレタンフォーム成型用ポリオール組成物。 (1) A polyol composition for molding flexible polyurethane foam containing a polyol component (A), a catalyst (B), a foam stabilizer (C), a blowing agent (D), and a crosslinking agent (E). A soft material containing a carbohydrate (E-1) as E), characterized in that the amount of the carbohydrate (E-1) added is 0.1 to 5% by mass based on the polyol component (A). Polyol composition for molding polyurethane foam.
(2)前記糖質(E-1)が、単糖類~十糖類から選ばれる少なくとも一種を含む、上記(1)に記載の軟質ポリウレタンフォーム成型用ポリオール組成物。 (2) The polyol composition for molding flexible polyurethane foam according to (1) above, wherein the carbohydrate (E-1) contains at least one selected from monosaccharides to decasaccharides.
(3)前記糖質(E-1)の平均糖鎖数が1.0以上9.0以下である、上記(1)、または(2)に記載の軟質ポリウレタンフォーム成型用ポリオール組成物。 (3) The polyol composition for molding flexible polyurethane foam according to (1) or (2) above, wherein the average number of sugar chains of the carbohydrate (E-1) is 1.0 or more and 9.0 or less.
(4)前記ポリオール成分(A)中に、触媒として複合金属シアン化物錯体触媒、ホスファゼン触媒、及びイミノ基含有ホスファゼニウム塩から選ばれる少なくとも一種を用いて製造された、総不飽和度0.001~0.04meq./gのポリオキシアルキレンポリオール(A-1)を含むことを特徴とする、上記(1)乃至(3)のいずれかに記載の軟質ポリウレタンフォーム成型用ポリオール組成物。 (4) Polyol component (A) produced using at least one selected from a multimetal cyanide complex catalyst, a phosphazene catalyst, and an imino group-containing phosphazenium salt as a catalyst, with a total unsaturation degree of 0.001 to 0.04meq. /g of polyoxyalkylene polyol (A-1).
(5)上記(1)乃至(4)のいずれかに記載の軟質ポリウレタンフォーム成型用ポリオール組成物と、ポリイソシアネート成分(F)とを含む軟質ポリウレタンフォーム成型用組成物であって、前記ポリイソシアネート成分(F)が、ジフェニルメタンジイソシアネートを50~85質量%の範囲で含み、該ジフェニルメタンジイソシアネートに含まれる2,2’-ジフェニルメタンジイソシアネートと、2,4’-ジフェニルメタンジイソシアネートの総量が該ジフェニルメタンジイソシアネートの総量に対し10~50質量%であることを特徴とする軟質ポリウレタンフォーム成型用組成物。 (5) A flexible polyurethane foam molding composition comprising the flexible polyurethane foam molding polyol composition according to any one of (1) to (4) above, and a polyisocyanate component (F), wherein the polyisocyanate component Component (F) contains diphenylmethane diisocyanate in a range of 50 to 85% by mass, and the total amount of 2,2'-diphenylmethane diisocyanate and 2,4'-diphenylmethane diisocyanate contained in the diphenylmethane diisocyanate is the total amount of the diphenylmethane diisocyanate. A flexible polyurethane foam molding composition characterized in that the content is 10 to 50% by mass.
(6)上記(5)に記載の軟質ポリウレタンフォーム成型用組成物を反応発泡させてなる軟質ポリウレタンフォーム。 (6) A flexible polyurethane foam obtained by reaction foaming the flexible polyurethane foam molding composition described in (5) above.
(7)上型側が下面、下型側が上面となるようにモールド成型された軟質ポリウレタンフォームを、上面側の端面から下面側に向かって厚みの45%毎に切り出した2層のフォームにおいて、2層それぞれのフォームの25%圧縮硬度の平均値を100とした際の上面側フォームの硬度比が50~85%であることを特徴とする、上記(6)に記載の軟質ポリウレタンフォーム。 (7) In a two-layer foam cut out from a flexible polyurethane foam molded so that the upper mold side is the lower surface and the lower mold side is the upper surface, every 45% of the thickness is cut from the upper end surface toward the lower surface. The flexible polyurethane foam according to (6) above, wherein the hardness ratio of the upper foam is 50 to 85% when the average value of the 25% compression hardness of the foam of each layer is 100.
(8)見掛け密度が30~70kg/m3であり、かつスキン付きフォーム試験片の25%圧縮硬さが100~350N/314cm2であり、かつ伸び率が100%以上であることを特徴とする、上記(6)、又は(7)に記載の軟質ポリウレタンフォーム。 (8) The apparent density is 30 to 70 kg/m 3 , the 25% compression hardness of the skinned foam test piece is 100 to 350 N/314 cm 2 , and the elongation is 100% or more. The flexible polyurethane foam according to (6) or (7) above.
(9)反発弾性率が45~75%であり、かつ湿熱圧縮歪みが20%未満であることを特徴とする、上記(6)乃至(8)のいずれかに記載の軟質ポリウレタンフォーム。 (9) The flexible polyurethane foam according to any one of (6) to (8) above, which has a rebound modulus of 45 to 75% and a wet heat compressive strain of less than 20%.
本発明の軟質ポリウレタンフォーム成型用ポリオール組成物を用いることにより、クッション材として用いたときの座り心地が良好な硬度分布を有する、軟質ポリウレタンフォームを得ることが可能となる。 By using the polyol composition for molding flexible polyurethane foam of the present invention, it is possible to obtain a flexible polyurethane foam that has a hardness distribution that provides good seating comfort when used as a cushioning material.
本発明を更に詳細に説明する。 The present invention will be explained in more detail.
本発明における軟質ポリウレタンフォーム成型用ポリオール組成物は、以下に示すポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、及び架橋剤(E)を含む。 The polyol composition for molding flexible polyurethane foam in the present invention contains a polyol component (A), a catalyst (B), a foam stabilizer (C), a blowing agent (D), and a crosslinking agent (E) shown below.
ポリオール成分(A)は、ポリイソシアネート成分(F)と重付加してポリウレタンを形成するものであり、本発明においては、ポリエーテルポリオール、及びポリエステルポリオールからなる群より選ばれる少なくとも一種であることが望ましい。さらに、数平均分子量1,000~10,000で、公称官能基数2以上のものがより望ましい。数平均分子量が下限未満では、得られるフォームの柔軟性が不足しやすく、上限を超えると、フォームの硬度が低下しやすい。また、公称官能基数が2未満の場合、耐久性の指標である湿熱圧縮歪みが悪くなるといった問題が発生する恐れがある。なお。公称官能基数とは、ポリオールの重合反応中に副反応が生じないと仮定した場合の理論平均官能基数(分子当たりの活性水素原子の数)を示す。 The polyol component (A) is polyadded with the polyisocyanate component (F) to form polyurethane, and in the present invention, it is at least one selected from the group consisting of polyether polyols and polyester polyols. desirable. Further, it is more desirable to have a number average molecular weight of 1,000 to 10,000 and a nominal number of functional groups of 2 or more. When the number average molecular weight is less than the lower limit, the resulting foam tends to lack flexibility, and when it exceeds the upper limit, the hardness of the foam tends to decrease. Moreover, when the number of nominal functional groups is less than 2, there is a possibility that a problem such as deterioration of wet heat compression strain, which is an index of durability, may occur. In addition. The nominal number of functional groups refers to the theoretical average number of functional groups (the number of active hydrogen atoms per molecule) assuming that no side reactions occur during the polymerization reaction of the polyol.
ポリエーテルポリオールとしては、例えばポリプロピレンエーテルポリオール、ポリエチレンポリプロピレンエーテルポリオール(以下、PPGと言う。)やポリテトラメチレンエーテルグリコール(以下、PTGと言う。)等が使用でき、ポリエステルポリオールとしては、例えば重縮合型ポリエステル系ポリオールであるアジピン酸とジオールからなるポリエステルポリオール、ラクトン系ポリエステルポリオールのポリカプロラクトンポリオール等が使用できる。 As the polyether polyol, for example, polypropylene ether polyol, polyethylene polypropylene ether polyol (hereinafter referred to as PPG), polytetramethylene ether glycol (hereinafter referred to as PTG), etc. can be used, and as the polyester polyol, for example, polycondensation Polyester polyols consisting of adipic acid and diol, which are type polyester polyols, and polycaprolactone polyols, which are lactone type polyester polyols, can be used.
本発明においては、フォームの耐久性改善の観点から、ポリオール成分(A)中に、触媒として複合金属シアン化物錯体触媒、ホスファゼン触媒、及びイミノ基含有ホスファゼニウム塩から選ばれる少なくとも一種を用いて製造された、総不飽和度0.001~0.04meq./gのポリオキシアルキレンポリオール(A―1)を含むことが好ましい。ポリオール(A―1)の総不飽和度が大きくなることは、末端に不飽和基をもつモノオール成分等が多くなることを意味し、総不飽和度が0.04meq./gよりも大きい場合は、フォームの架橋密度低下に伴い耐久性が低下する恐れがある。また0.001meq./gよりも小さいものは、製造時間を多く要するため好ましくない。 In the present invention, from the viewpoint of improving the durability of the foam, the polyol component (A) is produced using at least one selected from a multimetal cyanide complex catalyst, a phosphazene catalyst, and an imino group-containing phosphazenium salt as a catalyst. In addition, the total unsaturation degree is 0.001 to 0.04 meq. /g of polyoxyalkylene polyol (A-1). An increase in the total unsaturation degree of the polyol (A-1) means that the monool component having an unsaturated group at the terminal increases, and the total unsaturation degree is 0.04 meq. If it is larger than /g, there is a risk that the durability of the foam will decrease as the crosslinking density of the foam decreases. Also 0.001meq. If it is smaller than /g, it is not preferable because it requires a lot of manufacturing time.
また、本発明においては、ポリオール成分(A)中に、軟質ポリウレタンフォームの破泡を促進する目的で、オキシエチレンとオキシプロピレンとの共重合体からなるポリオキシアルキレン鎖を有する、ポリエーテルポリオールを含むことが好ましい。該ポリエーテルポリオールの数平均分子量は、4,000~8,000が好ましく、6,000~8,000がより好ましい。また、公称官能基数が2~4であることが好ましい。さらに、該ポリエーテルポリオール中のオキシエチレン単位が60~90質量%であることが好ましく、60~80質量%がより好ましい。オキシエチレン単位を60~90質量%とすることで、フォームの硬度分布が得られやすくなり、耐久性をより向上させることができる。また低温での貯蔵安定性の観点から、オキシエチレンとオキシプロピレンからなる共重合体はランダム共重合体であることが好ましい。 In addition, in the present invention, a polyether polyol having a polyoxyalkylene chain consisting of a copolymer of oxyethylene and oxypropylene is added to the polyol component (A) for the purpose of promoting foam breaking of the flexible polyurethane foam. It is preferable to include. The number average molecular weight of the polyether polyol is preferably 4,000 to 8,000, more preferably 6,000 to 8,000. Further, it is preferable that the nominal number of functional groups is 2 to 4. Furthermore, the amount of oxyethylene units in the polyether polyol is preferably 60 to 90% by mass, more preferably 60 to 80% by mass. By setting the oxyethylene unit content to 60 to 90% by mass, the hardness distribution of the foam can be easily obtained, and the durability can be further improved. Further, from the viewpoint of storage stability at low temperatures, the copolymer consisting of oxyethylene and oxypropylene is preferably a random copolymer.
該ポリエーテルポリオールの添加量は、ポリオール成分(A)に対して、0.5~5質量%が好ましい。下限値未満ではフォームの成型性が悪化する恐れがあり、上限値を超えるとフォームの伸び率が低下する恐れがある。 The amount of the polyether polyol added is preferably 0.5 to 5% by mass based on the polyol component (A). If it is less than the lower limit, the moldability of the foam may deteriorate, and if it exceeds the upper limit, the elongation rate of the foam may decrease.
本発明のポリオール成分(A)には、硬さ調整を目的として、ポリオール中でビニル系モノマーを通常の方法で重合したポリマーポリオールを併用することが好ましい。このようなポリマーポリオールとしては、例えば前記PPG等のポリアルキレンポリオール中、ラジカル開始剤の存在下でビニル系モノマーを重合させ、安定分散させたものが挙げられる。また、ビニル系モノマーとしては、例えばアクリロニトリル、スチレン、塩化ビニリデン、ヒドロキシアルキルメタアクリレート、アルキルメタアクリレートが挙げられ、中でもアクリロニトリル、スチレンが好ましい。このようなポリマーポリオールとしては、例えばAGC社製のEL-910、EL-923、三洋化成工業社製のFA-728R等が挙げられる。 For the purpose of hardness adjustment, it is preferable to use a polymer polyol obtained by polymerizing a vinyl monomer in a polyol by a conventional method as the polyol component (A) of the present invention. Examples of such polymer polyols include those obtained by polymerizing and stably dispersing a vinyl monomer in a polyalkylene polyol such as the above-mentioned PPG in the presence of a radical initiator. Examples of vinyl monomers include acrylonitrile, styrene, vinylidene chloride, hydroxyalkyl methacrylate, and alkyl methacrylate, with acrylonitrile and styrene being preferred. Examples of such polymer polyols include EL-910 and EL-923 manufactured by AGC, and FA-728R manufactured by Sanyo Chemical Industries.
触媒(B)としては、当該分野において公知である各種のウレタン化触媒を使用でき、例えば、トリエチルアミン、トリプロピルアミン、トリブチルアミン、N-メチルモリホリン、N-エチルモリホリン、ジメチルベンジルアミン、N,N,N’,N’-テトラメチルヘキサメチレンジアミン、N,N,N’,N’,N’’-ペンタメチルジエチレントリアミン、ビス-(2-ジメチルアミノエチル)エーテル、トリエチレンジアミン、1,8-ジアザ-ビシクロ[5.4.0]ウンデセン-7、1,2-ジメチルイミダゾール、ジメチルエタノールアミン、N,N-ジメチル-N-ヘキサノールアミン、さらにこれらの有機酸塩、スタナスオクトエート、ナフテン酸亜鉛等の有機金属化合物等も挙げられる。また、N,N-ジメチルエタノールアミン、N,N-ジエチルエタノールアミン等の活性水素を有すアミン触媒も好ましい。 As the catalyst (B), various urethanization catalysts known in the art can be used, such as triethylamine, tripropylamine, tributylamine, N-methylmorpholine, N-ethylmorpholine, dimethylbenzylamine, N ,N,N',N'-tetramethylhexamethylenediamine, N,N,N',N',N''-pentamethyldiethylenetriamine, bis-(2-dimethylaminoethyl)ether, triethylenediamine, 1,8 -Diaza-bicyclo[5.4.0]undecene-7,1,2-dimethylimidazole, dimethylethanolamine, N,N-dimethyl-N-hexanolamine, and organic acid salts thereof, stannous octoate, naphthene Also included are organometallic compounds such as zinc oxide. Also preferred are amine catalysts having active hydrogen such as N,N-dimethylethanolamine and N,N-diethylethanolamine.
触媒の添加量は、ポリオール成分(A)に対して、0.01~10質量%が好ましい。下限値未満ではキュア不足になりやすく、上限値を超えると成形性が悪化する恐れがある。 The amount of catalyst added is preferably 0.01 to 10% by mass based on the polyol component (A). If it is less than the lower limit, curing tends to be insufficient, and if it exceeds the upper limit, moldability may deteriorate.
整泡剤(C)としては、通常の界面活性剤が使用され、有機珪素系の界面活性剤が好適に使用できる。例えば、東レ・ダウコーニング社製のSZ-1327、SZ-1325、SZ-1336、SZ-3601、モメンティブ社製のY-10366、L-5309、エボニック社製のB-8724LF2、B-8715LF2等が挙げられる。これら整泡剤の添加量はポリオール成分(A)に対して0.1~3質量%が好ましい。 As the foam stabilizer (C), ordinary surfactants are used, and organic silicon-based surfactants are preferably used. For example, SZ-1327, SZ-1325, SZ-1336, SZ-3601 manufactured by Dow Corning Toray, Y-10366, L-5309 manufactured by Momentive, B-8724LF2, B-8715LF2 manufactured by Evonik, etc. Can be mentioned. The amount of these foam stabilizers added is preferably 0.1 to 3% by mass based on the polyol component (A).
発泡剤(D)としては、主として水を用いる。水はイソシアネート基との反応で高硬度のウレア基を形成すると共に炭酸ガスを発生し、これにより発泡させることができる。また、水と付加的に任意の発泡剤を使用してもよい。例えば、少量のシクロペンタンやイソペンタン等の低沸点有機化合物を併用してもよいし、ガスローディング装置を用いて原液中に空気や窒素ガスや液化二酸化炭素を混入溶解させて発泡することもできる。発泡剤の添加量は、通常ポリオール成分(A)に対して0.5~10質量%であるが、見掛け密度40kg/m3未満の低密度軟質ポリウレタンフォームを得る場合、3.0~6.0質量%であることが好ましく、3.0~5.5質量%が更に好ましい。上限を超えると発泡が安定し難くなる恐れがあり、下限未満では発泡体の密度を十分に下げることができない恐れがある。 Water is mainly used as the blowing agent (D). Water reacts with isocyanate groups to form highly hard urea groups and also generates carbon dioxide gas, which can cause foaming. Additionally, any blowing agent may be used in addition to water. For example, a small amount of a low boiling point organic compound such as cyclopentane or isopentane may be used in combination, or air, nitrogen gas, or liquefied carbon dioxide may be mixed and dissolved in the stock solution using a gas loading device to cause foaming. The amount of the blowing agent added is usually 0.5 to 10% by mass based on the polyol component (A), but when obtaining a low density flexible polyurethane foam with an apparent density of less than 40 kg/m 3 , the amount added is 3.0 to 6% by mass. It is preferably 0% by weight, more preferably 3.0 to 5.5% by weight. If the upper limit is exceeded, foaming may become difficult to stabilize, and if it is less than the lower limit, the density of the foam may not be sufficiently lowered.
本発明における架橋剤(E)は、糖質(E-1)を含有する。糖質(E-1)としては、単糖類~十糖類から選ばれる少なくとも一種を含むことが好ましく、単糖類~六糖類から選ばれる少なくとも一種を含むことが更に好ましい。なお、単糖類は糖質の最小単位であり、二糖類~十糖類とは、2~10個の単糖類が脱水縮合し、グリコシド結合を形成して1分子となったものそれぞれを意味する。 The crosslinking agent (E) in the present invention contains a carbohydrate (E-1). The carbohydrate (E-1) preferably contains at least one selected from monosaccharides to decasaccharides, and more preferably at least one selected from monosaccharides to hexasaccharides. Note that monosaccharides are the smallest units of carbohydrates, and disaccharides to decasaccharides refer to 2 to 10 monosaccharides dehydrated and condensed to form glycosidic bonds to form one molecule.
このうち単糖類としては、例えば、トリオース、テトロース、ペントース、ヘキソース、ヘプトース、オクトース、ノノース、デコースなどが挙げられる。これらの化合物は、アルドースやケトースであってもよく、ジアルドース(糖の誘導体であって炭素鎖両末端がアルデヒド基である化合物、例えば、テトラアセチルガラクトヘキソジアルドース、イドヘキソジアルドース、キシロペントドアルドース等)、複数のカルボニル基を有する単糖類(オソン、オノース等のアルドアルコケトース等)、メチル基を有する単糖類(アルトロメチロースなどのメチル糖等)、アシル基(特にアセチル基などのC2-C4アシル基等)を有する単糖類(前記アルドースのアセチル体、例えば、アルデヒドグルコースペンタアセチル化合物などのアセチル体など)、カルボキシル基が導入された糖質(糖酸またはウロン酸等)、リオ糖、アミノ糖、デオキシ糖などであってもよい。 Among these, examples of monosaccharides include triose, tetrose, pentose, hexose, heptose, octose, nonose, and decose. These compounds may be aldoses or ketoses, and dialdoses (compounds that are sugar derivatives and have aldehyde groups at both ends of the carbon chain, such as tetraacetylgalactohexodialdose, idohexodialdose, xylopentodo) aldose, etc.), monosaccharides with multiple carbonyl groups (aldoalkoketoses such as othone, onose, etc.), monosaccharides with methyl groups (methyl sugars such as altromethylose, etc.), acyl groups (especially C2 -C4 acyl group, etc.) (acetyl form of the above-mentioned aldose, for example, acetyl form such as aldehyde glucose pentaacetyl compound, etc.), carbohydrates into which a carboxyl group has been introduced (saccharide acid or uronic acid, etc.), liosaccharide , amino sugar, deoxy sugar, etc.
このような単糖類としては、例えば、テトロース(エリトロース、トレオロース等)、ペントース(アラビノース、リボース、リキソース、デオキシリボース、キシロース等)、ヘキソース(アロース、アルトロース、グルコース、マンノース、グロース、イドース、ガラクトース、フルクトース、ソルボース、フコース、ラムノース、タロース、ガラクチュロン酸、グルクロン酸、マンヌロン酸、グルコサミン等)などが例示できる。 Examples of such monosaccharides include tetrose (erythrose, threolose, etc.), pentose (arabinose, ribose, lyxose, deoxyribose, xylose, etc.), hexose (allose, altrose, glucose, mannose, gulose, idose, galactose, Examples include fructose, sorbose, fucose, rhamnose, talose, galacturonic acid, glucuronic acid, mannuronic acid, glucosamine, etc.).
また、単糖類は、ヘミアセタール結合により環状構造を形成した環状異性体であってもよい。単糖類は旋光性を有している必要はなく、D型、L型、DL型のいずれであってもよい。また、結晶体であっても液状であってもよく、水和物であっても水を含んでいてもよい。これらの単糖類は単独で又は二種以上組み合わせて使用できる。特に高果糖液糖、果糖ぶどう糖液糖、ぶどう糖果糖液糖等の常温液状である異性化液糖は、軟質ポリウレタンフォーム成型用ポリオール組成物調製時の作業性、軟質ポリウレタンフォーム成型用ポリオール組成物の貯蔵安定性の面でより好ましい。 Further, the monosaccharide may be a cyclic isomer having a cyclic structure formed by a hemiacetal bond. The monosaccharide does not need to have optical rotation, and may be any of the D-type, L-type, and DL-type. Further, it may be in a crystalline state or a liquid state, and may be a hydrate or contain water. These monosaccharides can be used alone or in combination of two or more. In particular, isomerized liquid sugars that are liquid at room temperature, such as high fructose corn syrup, high fructose corn syrup, and high-fructose corn syrup, are useful for improving workability during the preparation of polyol compositions for molding flexible polyurethane foams. More preferred in terms of storage stability.
二糖類としては、トレハロース(例えば、α,α―トレハロース、β,β―トレハロース、α,β―トレハロースなど)コージービオース、ニゲロース、マルトース、イソマルトース、ソホロース、ラミナリビオース、セロビオース、ゲンチオビオース、ラクトース、スクロース、パラチノース、メリビオース、ルチノース、プリメベロース、ツラノース等が挙げられる。これらの単糖類、二糖類は単独で又は二種以上組み合わせて使用できるが、前述の通り常温液状である糖質の常温液状混合物や、エチレングリコール、ジエチレングリコール、グリセリンなど親水性ポリオールとの常温液状混合物として使用することが、より好ましい。 Disaccharides include trehalose (e.g. α,α-trehalose, β,β-trehalose, α,β-trehalose, etc.) cozybiose, nigerose, maltose, isomaltose, sophorose, laminaribiose, cellobiose, gentiobiose, lactose. , sucrose, palatinose, melibiose, rutinose, primeverose, turanose, and the like. These monosaccharides and disaccharides can be used alone or in combination of two or more, but as mentioned above, a room-temperature liquid mixture of carbohydrates that is liquid at room temperature, or a room-temperature liquid mixture with a hydrophilic polyol such as ethylene glycol, diethylene glycol, or glycerin. It is more preferable to use it as
三糖類~十糖類は一般にオリゴ糖とも呼ばれ(以下、三糖類~十糖類をオリゴ糖と称する場合がある。)、3~10分子の単糖類が、グリコシド結合を介して脱水縮合したホモオリゴ糖と、少なくとも2種類以上の3~10分子の単糖類及び/又は糖アルコールが、グリコシド結合を介して脱水縮合したヘテロオリゴ糖に大別される。本発明に用いることができるオリゴ糖としては、三糖類~十糖類が好ましく、三糖類~六糖類がより好ましい。なお、これらのオリゴ糖は環状構造を有していてもよいし、無水物でも水和物でもよい。また、オリゴ糖において、単糖類と糖アルコールとが結合していてもよい。これらのオリゴ糖は単独で、または二種類以上組み合わせて使用でき、単糖類、二糖類、多糖類との組み合わせでも使用できる。なお、オリゴ糖は複数の糖成分で構成されたオリゴ糖組成物であってもよい。このようなオリゴ糖組成物であっても単にオリゴ糖という場合がある。オリゴ糖においても、常温固体であるものは、他の糖質やグリセリンなどの親水性ポリオールと混合することで常温液状化して使用することが好ましい。 Trisaccharides to decasaccharides are generally also called oligosaccharides (hereinafter, trisaccharides to decasaccharides may be referred to as oligosaccharides), and are homooligosaccharides in which 3 to 10 molecules of monosaccharides are dehydrated and condensed via glycosidic bonds. and hetero-oligosaccharides, in which at least two or more types of 3 to 10 molecules of monosaccharides and/or sugar alcohols are dehydrated and condensed via glycosidic bonds. The oligosaccharides that can be used in the present invention are preferably trisaccharides to decasaccharides, and more preferably trisaccharides to hexasaccharides. Note that these oligosaccharides may have a cyclic structure, and may be anhydrous or hydrated. Furthermore, in the oligosaccharide, a monosaccharide and a sugar alcohol may be bonded. These oligosaccharides can be used alone or in combination of two or more, and can also be used in combination with monosaccharides, disaccharides, and polysaccharides. Note that the oligosaccharide may be an oligosaccharide composition composed of a plurality of sugar components. Even such an oligosaccharide composition may be simply referred to as an oligosaccharide. Among oligosaccharides, those that are solid at room temperature are preferably used after being liquefied at room temperature by mixing with other carbohydrates or hydrophilic polyols such as glycerin.
三糖類としては、マルトトリオース、イソマルトトリオース、パノース、セロトリオースなどのホモオリゴ糖;マンニノトリオース、ソラトリオース、メレジトース、プランテオース、ゲンチアノース、ウンベリフェロース、ラクトスクロース、ラフィノースなどのヘテロオリゴ糖が挙げられる。 Examples of trisaccharides include homo-oligosaccharides such as maltotriose, isomaltotriose, panose, and cellotriose; hetero-oligosaccharides such as manninotriose, solatriose, melezitose, planteose, gentianose, umbelliferose, lactosucrose, and raffinose. It will be done.
四糖類としては、マルトテトラオース、イソマルトテトラオースなどのホモオリゴ糖;スタキオース、セロテトラオース、スコロドース、リキノース、パノースの還元末端に糖又は糖アルコールが結合したテロラオースなどのヘテロオリゴ糖などが挙げられる。 Examples of the tetrasaccharide include homo-oligosaccharides such as maltotetraose and isomaltotetraose; hetero-oligosaccharides such as stachyose, cellotetraose, scorodose, liquinose, and telolaose, in which a sugar or sugar alcohol is bound to the reducing end of panose.
五糖類としては、マルトペンタオース、イソマルトペンタオースなどのホモオリゴ糖;パノースの還元末端に二糖類が結合したペンタオースなどのヘテロオリゴ糖などが挙げられる。 Examples of pentasaccharides include homo-oligosaccharides such as maltopentaose and isomaltopentaose; hetero-oligosaccharides such as pentaose in which a disaccharide is bonded to the reducing end of panose.
六糖類としてはマルトヘキサオース、イソマルトヘキサオースなどのホモオリゴ糖などが挙げられる。 Examples of hexasaccharides include homooligosaccharides such as maltohexaose and isomaltohexaose.
環状オリゴ糖としてはα―シクロデキストリン(六糖類)、β―シクロデキストリン(七糖類)、γ―シクロデキストリン(八糖類)が挙げられる。 Examples of the cyclic oligosaccharide include α-cyclodextrin (hexasaccharide), β-cyclodextrin (heptasaccharide), and γ-cyclodextrin (octasaccharide).
オリゴ糖は還元型(マルトース型)であってもよく、非還元型(トレハロース型)であってもよい。 The oligosaccharide may be a reduced type (maltose type) or a non-reduced type (trehalose type).
多糖類としてはアミロース、アミロペクチン、グリコーゲン、セルロース、寒天、イヌリン、グルコマンナン、グリコサミノグリカン(ムコ多糖)、アルギン酸、ヒアルロン酸、コンドロイチン酸、ヘパリン、キチン等が挙げられる。 Examples of polysaccharides include amylose, amylopectin, glycogen, cellulose, agar, inulin, glucomannan, glycosaminoglycan (mucopolysaccharide), alginic acid, hyaluronic acid, chondroitic acid, heparin, and chitin.
ポリオール成形用組成物を構成する他の成分と糖質との混合性改善などの目的で、単糖類、二糖類、オリゴ糖類およびこれらの混合物は、その水酸基の一部をエーテル変性やエステル変性しても良い。ただし、変性による水酸基濃度減少によって本発明の効果は小さくなることから、変性可能な水酸基は、全水酸基の30mol%以下であることが好ましい。 Monosaccharides, disaccharides, oligosaccharides, and mixtures thereof may be modified with ethers or esters to partially modify their hydroxyl groups for the purpose of improving the miscibility of carbohydrates and other components constituting the polyol molding composition. It's okay. However, since the effect of the present invention decreases due to a decrease in the concentration of hydroxyl groups due to modification, it is preferable that the amount of hydroxyl groups that can be modified is 30 mol % or less of the total hydroxyl groups.
糖質(E―1)の数平均分子量は180~2,500であることが好ましく、180~1,800であることが更に好ましい。上限値を超えるとフォームの成形性やフォームの伸び率が悪化する恐れがある。 The number average molecular weight of the carbohydrate (E-1) is preferably 180 to 2,500, more preferably 180 to 1,800. If the upper limit is exceeded, the moldability of the foam and the elongation rate of the foam may deteriorate.
糖質(E―1)の平均糖鎖数は1.0以上9.0以下であることが好ましく、更に好ましくは1.0を超えて9.0以下であり、最も好ましくは1.5以上9.0以下である。ここで、糖鎖数とは単糖類が繋がった個数であり、平均糖鎖数とは、糖質(E―1)中に含まれる各成分の糖鎖数を平均したものである。下限値未満では十分な伸び率が得られにくく、上限値を超えるとフォームの成形性やフォームの伸び率が悪化する恐れがある。 The average number of sugar chains of the carbohydrate (E-1) is preferably 1.0 or more and 9.0 or less, more preferably more than 1.0 and 9.0 or less, and most preferably 1.5 or more. It is 9.0 or less. Here, the number of sugar chains is the number of linked monosaccharides, and the average number of sugar chains is the average number of sugar chains of each component contained in the carbohydrate (E-1). If it is less than the lower limit, it is difficult to obtain a sufficient elongation rate, and if it exceeds the upper limit, the moldability of the foam and the elongation rate of the foam may deteriorate.
また、糖質(E―1)の平均水酸基数は、平均炭素原子数に対して0.5倍以上であることが好ましい。ここで、平均水酸基数とは、糖質(E―1)中の各成分の水酸基数を平均したものであり、平均炭素原子数とは、糖質(E―1)中の各成分の炭素原子数を平均したものである。 Furthermore, the average number of hydroxyl groups in the carbohydrate (E-1) is preferably 0.5 times or more the average number of carbon atoms. Here, the average number of hydroxyl groups is the average number of hydroxyl groups of each component in the carbohydrate (E-1), and the average number of carbon atoms is the average number of carbon atoms of each component in the carbohydrate (E-1). It is the average number of atoms.
糖質(E―1)の添加量は、ポリオール成分(A)に対して0.1~5質量%であり、好ましくは0.1~4質量%であり、より好ましくは0.3~4質量%である。下限値未満では硬度分布の発現効果が得られにくく、上限値を超えるとフォームの成形性やフォームの伸び率が悪化する恐れがある。 The amount of carbohydrate (E-1) added is 0.1 to 5% by mass, preferably 0.1 to 4% by mass, more preferably 0.3 to 4% by mass based on polyol component (A). Mass%. If it is less than the lower limit, it is difficult to obtain the effect of developing hardness distribution, and if it exceeds the upper limit, the moldability of the foam and the elongation rate of the foam may deteriorate.
また、本発明においては、フォームの伸び率や湿熱圧縮歪みといった物性面改善の観点から、軟質ポリウレタンフォーム成型用ポリオール組成物中に糖質(E―1)以外の架橋剤成分として脂環族グリコールおよび芳香族グリコールからなる群より選ばれる少なくとも一種の環状グリコール(以下単に「環状グリコール」とも言う。)を含むことが好ましい。環状グリコールとは、化合物中に環構造を有するものであり、例えば、シクロヘキサンジオール、シクロヘキサンジメタノール、ヒドロキノンビス(2-ヒドロキシエチル)エーテル、ジヒドロキシジフェニルメタン、ビスフェノールA水素化物、ポリオキシエチレンビスフェノールエーテル、ポリオキシプロピレンビスフェノールエーテル等を挙げることができる。これらの中でも、得られる軟質ポリウレタンフォームの湿熱圧縮歪みの改善効果が高いという観点から、1,4-シクロヘキサンジメタノール、ポリオキシエチレンビスフェノールAエーテルが好ましい。環状グリコールの含有量は、ポリオール成分(A)に対して1.5~8質量%であることが好ましく、1.5~6質量%であることが更に好ましい。 In addition, in the present invention, from the viewpoint of improving physical properties such as foam elongation and wet heat compression strain, alicyclic glycol is added as a crosslinking agent component other than carbohydrate (E-1) in the polyol composition for molding flexible polyurethane foam. and aromatic glycols (hereinafter also simply referred to as "cyclic glycol"). Cyclic glycols are compounds that have a ring structure, such as cyclohexanediol, cyclohexanedimethanol, hydroquinone bis(2-hydroxyethyl) ether, dihydroxydiphenylmethane, bisphenol A hydride, polyoxyethylene bisphenol ether, and Oxypropylene bisphenol ether and the like can be mentioned. Among these, 1,4-cyclohexanedimethanol and polyoxyethylene bisphenol A ether are preferred from the viewpoint of having a high effect of improving the moist heat compression strain of the resulting flexible polyurethane foam. The content of cyclic glycol is preferably 1.5 to 8% by mass, more preferably 1.5 to 6% by mass, based on the polyol component (A).
以上のポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、及び架橋剤(E)を含むポリオール組成物を用いることにより、クッション材として用いたときの座り心地が良好な、垂直方向に硬度分布を有する軟質ポリウレタンフォームを得ることが可能となる。 By using a polyol composition containing the above polyol component (A), catalyst (B), foam stabilizer (C), foaming agent (D), and crosslinking agent (E), it is possible to improve the seating resistance when used as a cushioning material. It becomes possible to obtain a soft polyurethane foam that is comfortable and has a hardness distribution in the vertical direction.
本発明の軟質ポリウレタンフォームの製造に用いられるポリイソシアネート成分(F)は、4,4’-ジフェニルメタンジイソシアネート(以下、4,4’-MDI)、2,4’-ジフェニルメタンジイソシアネート(以下、2,4’-MDI)、2,2’-ジフェニルメタンジイソシアネート(以下、2,2’-MDI)、等のジフェニルメタンジイソシアネート(以下、MDI)、ポリフェニレンポリメチレンポリイソシアネート(以下、P-MDI)をイソシアネート源として用いることが好ましい。本発明においては、上記したMDI、MDIとP-MDIとの混合物、ウレタン変性体、ウレア変性体、アロファネート変性体、ヌレート変性体、ビュウレット変性体等の各種変性体も使用し得る。 The polyisocyanate component (F) used in the production of the flexible polyurethane foam of the present invention is 4,4'-diphenylmethane diisocyanate (hereinafter referred to as 4,4'-MDI), 2,4'-diphenylmethane diisocyanate (hereinafter referred to as 2,4 '-MDI), 2,2'-diphenylmethane diisocyanate (hereinafter referred to as 2,2'-MDI), diphenylmethane diisocyanate (hereinafter referred to as MDI), polyphenylene polymethylene polyisocyanate (hereinafter referred to as P-MDI) are used as the isocyanate source. It is preferable. In the present invention, various modified products such as the above-described MDI, a mixture of MDI and P-MDI, a urethane modified product, a urea modified product, an allophanate modified product, a nurate modified product, a biuret modified product, etc. can also be used.
本発明にかかるポリイソシアネート成分(F)のMDI含有率は、50~85質量%の範囲が好ましい。MDI含有率が85質量%を超えると、ポリイソシアネート成分の低温における貯蔵安定性や得られる軟質ポリウレタンフォームの耐久性が低下する恐れがあり、他方、50質量%未満では架橋密度の上昇に伴い、軟質ポリウレタンフォームの伸びが低下し、十分なフォーム強度を得にくくなる恐れがある。 The MDI content of the polyisocyanate component (F) according to the present invention is preferably in the range of 50 to 85% by mass. If the MDI content exceeds 85% by mass, there is a risk that the storage stability of the polyisocyanate component at low temperatures and the durability of the resulting flexible polyurethane foam will decrease, while if it is less than 50% by mass, the crosslinking density will increase. The elongation of the flexible polyurethane foam may decrease, making it difficult to obtain sufficient foam strength.
さらに、MDI総量に対する2,2’-MDIの含有率と2,4’-MDIの含有率との合計(以下、アイソマー含有率)は10~50質量%が好ましい。 Further, the total content of 2,2'-MDI and 2,4'-MDI (hereinafter referred to as isomer content) relative to the total amount of MDI is preferably 10 to 50% by mass.
本発明にかかるMDI総量に対する2,2’-MDI及び2,4’-MDIの含有量が10質量%未満では、ポリイソシアネート成分の低温での貯蔵安定性が損なわれる恐れがあり、イソシアネート保管場所や配管、発泡成形機内の常時加温が必要となる場合がある。また軟質ポリウレタンフォームの成形安定性が損なわれ、発泡途中でのフォーム崩壊等が発生する恐れがある。他方、50質量%を超えると反応性が低下し、成形サイクルの延長、フォームの独泡率が高くなり成型後に収縮する等の問題が生じる恐れがある。 If the content of 2,2'-MDI and 2,4'-MDI with respect to the total amount of MDI according to the present invention is less than 10% by mass, the storage stability at low temperatures of the polyisocyanate component may be impaired, and the isocyanate storage location may be It may be necessary to constantly heat the pipes, pipes, and inside of the foam molding machine. Furthermore, the molding stability of the flexible polyurethane foam may be impaired, and the foam may collapse during foaming. On the other hand, if it exceeds 50% by mass, the reactivity decreases, which may cause problems such as lengthening of the molding cycle, high cell foam ratio, and shrinkage after molding.
そして、本発明における軟質ポリウレタンフォームの製造には、炭酸カルシウムや硫酸バリウムのような充填剤、難燃剤、可塑剤、着色剤、抗カビ剤等の公知の各種添加剤、助剤を必要に応じて使用することができる。 In the production of the flexible polyurethane foam of the present invention, various known additives and auxiliaries such as fillers such as calcium carbonate and barium sulfate, flame retardants, plasticizers, colorants, and antifungal agents are added as necessary. can be used.
本発明においては、上記した軟質ポリウレタンフォーム成型用ポリオール組成物とポリイソシアネート成分とから軟質ポリウレタンフォームを得ることができ、見掛け密度30kg/m3~70kg/m3、かつスキン付きフォーム試験片の25%圧縮硬さが100~350N/314cm2、かつ伸び率100%以上、さらに反発弾性率が45~75%、湿熱圧縮歪みが20%未満の、発泡方向に硬度分布を有する軟質ポリウレタンフォームを好適に得ることができる。 In the present invention, a flexible polyurethane foam can be obtained from the polyol composition for molding flexible polyurethane foam and a polyisocyanate component, and has an apparent density of 30 kg/m 3 to 70 kg/m 3 and a skinned foam test piece of 25 Suitable is a flexible polyurethane foam having a hardness distribution in the foaming direction, with a % compression hardness of 100 to 350 N/314 cm 2 , an elongation rate of 100% or more, a rebound modulus of 45 to 75%, and a moist heat compression strain of less than 20%. can be obtained.
次に、本発明の軟質ポリウレタンフォームの製造方法について説明する。 Next, the method for manufacturing the flexible polyurethane foam of the present invention will be explained.
本発明の軟質ポリウレタンフォームは、ポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、架橋剤(E)、及びポリイソシアネート成分(F)の混合液を反応発泡させて製造される。 The flexible polyurethane foam of the present invention is produced by reacting a mixed solution of a polyol component (A), a catalyst (B), a foam stabilizer (C), a blowing agent (D), a crosslinking agent (E), and a polyisocyanate component (F). Manufactured by foaming.
本発明のポリイソシアネート組成物中の全イソシアネート基と、水を含む活性水素基含有化合物中の全活性水素基との混合発泡時におけるモル比(NCO/活性水素)としては、0.7~1.4(イソシアネートインデックス(NCO INDEX)=70~140)であることが好ましく、フォームの耐久性や成形サイクルの良好な範囲として0.7~1.2(NCO INDEX=70~120)がより好ましい。 The molar ratio (NCO/active hydrogen) of all the isocyanate groups in the polyisocyanate composition of the present invention and all the active hydrogen groups in the active hydrogen group-containing compound containing water at the time of mixing and foaming is 0.7 to 1. .4 (isocyanate index (NCO INDEX) = 70 to 140) is preferable, and 0.7 to 1.2 (NCO INDEX = 70 to 120) is more preferable as a good range for foam durability and molding cycle. .
NCO INDEXが70未満では耐久性の低下や独泡性に過度の上昇が生じ、120より高い場合は未反応イソシアネートが長く残存することによる成形サイクルの延長、高分子量化の遅延によるフォーム発泡途中でのフォーム崩壊等が生じる恐れがある。 If the NCO INDEX is less than 70, the durability will decrease and the closed cell property will increase excessively, and if it is higher than 120, the molding cycle will be extended due to unreacted isocyanate remaining for a long time, and the foam foaming will be delayed during foaming due to the delay in polymerization. There is a risk of foam collapse, etc.
軟質ポリウレタンフォームの製造方法としては、前記ポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、架橋剤(E)、及びポリイソシアネート成分(F)の混合液の発泡原液を金型内に注入し、その後発泡硬化させることを特徴とする軟質ポリウレタンモールドフォーム(以下、軟質モールドフォーム)の製造方法が使用できる。 The method for producing flexible polyurethane foam includes a mixed solution of the polyol component (A), catalyst (B), foam stabilizer (C), blowing agent (D), crosslinking agent (E), and polyisocyanate component (F). A method for producing flexible polyurethane molded foam (hereinafter referred to as "flexible molded foam") can be used, which is characterized by injecting a foaming stock solution into a mold and then foaming and hardening.
上記発泡原液を金型内に注入する際の金型温度としては、通常30~80℃、好ましくは45~65℃である。上記発泡原液を金型内に注入する際の金型温度が30℃未満であると、反応速度低下による生産サイクルの延長につながり、一方、80℃より高いと、ポリオールとイソシアネートの反応に対し、水とイソシアネートとの反応が過度に促進されることにより、発泡途中においてフォームが崩壊する恐れがある。 The temperature of the mold when injecting the foaming stock solution into the mold is usually 30 to 80°C, preferably 45 to 65°C. If the mold temperature when injecting the foaming stock solution into the mold is less than 30°C, the reaction rate will decrease and the production cycle will be extended, while if it is higher than 80°C, the reaction between polyol and isocyanate will be delayed. If the reaction between water and isocyanate is excessively accelerated, the foam may collapse during foaming.
上記発泡原液を発泡硬化させる際の硬化時間としては、一般的な軟質モールドフォームの生産サイクルを考慮すると10分以下が好ましく、7分以下がより好ましい。 The curing time when foaming and curing the above-mentioned foaming stock solution is preferably 10 minutes or less, more preferably 7 minutes or less, considering the production cycle of general flexible molded foams.
軟質モールドフォームを製造する際には、通常の軟質モールドフォームの場合と同様、高圧発泡機や低圧発泡機等を用いて、上記各成分を混合することができる。 When producing a flexible molded foam, the above-mentioned components can be mixed using a high-pressure foaming machine, a low-pressure foaming machine, etc., as in the case of ordinary flexible molded foams.
イソシアネート成分とポリオール成分とは発泡直前で混合することが好ましい。その他の成分は、原料の貯蔵安定性や反応性の経時変化に影響を与えない範囲でイソシアネート成分またはポリオール成分と予め混合することができる。それら混合物は混合後直ちに使用しても、貯留した後、必要量を適宜使用してもよい。混合部に2成分を超える成分を同時に導入可能な発泡装置の場合、ポリオール、発泡剤、イソシアネート、触媒、整泡剤、添加剤等を個別に混合部に導入することもできる。 It is preferable that the isocyanate component and the polyol component are mixed immediately before foaming. Other components can be mixed in advance with the isocyanate component or polyol component to the extent that they do not affect the storage stability of the raw materials or changes in reactivity over time. These mixtures may be used immediately after mixing, or may be stored and then used in the required amount as appropriate. In the case of a foaming device that can simultaneously introduce more than two components into the mixing section, polyols, blowing agents, isocyanates, catalysts, foam stabilizers, additives, etc. can also be introduced individually into the mixing section.
また、混合方法は、発泡機のマシンヘッド混合室内で混合を行うダイナミックミキシング、送液配管内で混合を行うスタティックミキシングの何れでも良く、また両者を併用してもよい。物理発泡剤等のガス状成分と液状成分との混合はスタティックミキシングで、液体として安定に貯留可能な成分同士の混合はダイナミックミキシングで実施される場合が多い。本発明に使用される発泡装置は、混合部の溶剤洗浄が必要のない高圧発泡装置であることが好ましい。 Further, the mixing method may be either dynamic mixing in which mixing is performed in the mixing chamber of the machine head of the foaming machine, or static mixing in which mixing is performed within the liquid feeding pipe, or both may be used in combination. Mixing of a gaseous component such as a physical foaming agent and a liquid component is often performed by static mixing, and mixing of components that can be stably stored as a liquid is often performed by dynamic mixing. The foaming device used in the present invention is preferably a high-pressure foaming device that does not require solvent cleaning of the mixing section.
このような混合により得られた混合液を金型(モールド)内に吐出し、発泡硬化させ、その後脱型が行われる。上記脱型を円滑に行うため、金型に予め離型剤を塗布しておくことも好適である。使用する離型剤としては、成形加工分野で通常用いられる離型剤を用いればよい。 The liquid mixture obtained by such mixing is discharged into a mold, foamed and hardened, and then demolded. In order to perform the above-mentioned demolding smoothly, it is also suitable to apply a mold release agent to the mold in advance. As the mold release agent to be used, a mold release agent commonly used in the field of molding processing may be used.
脱型後の製品はそのままでも使用できるが、従来公知の方法で圧縮下又は、減圧下でフォームのセル膜を破壊し、以降の製品外観、寸法を安定化させることが好ましい。 Although the product after demolding can be used as is, it is preferable to destroy the cell membrane of the foam under compression or reduced pressure by a conventionally known method to stabilize the appearance and dimensions of the product thereafter.
上記した軟質ポリウレタンフォームの製造方法により、見掛け密度30kg/m3~70kg/m3、かつスキン付きフォーム試験片の25%圧縮硬さが100~350N/314cm2、反発弾性率が45~75%、湿熱圧縮歪みが20%未満である軟質ポリウレタンフォームを得ることができる。また、該軟質ポリウレタンフォームは、発泡方向に硬度分布を有する。 By the above-described manufacturing method of flexible polyurethane foam, the apparent density is 30 kg/m 3 to 70 kg/m 3 , the 25% compression hardness of the skinned foam test piece is 100 to 350 N/314 cm 2 , and the rebound modulus is 45 to 75%. , it is possible to obtain a flexible polyurethane foam with a wet heat compressive strain of less than 20%. Moreover, the flexible polyurethane foam has a hardness distribution in the foaming direction.
[軟質ポリウレタンフォームが硬度分布を呈するメカニズム]
本発明にかかる軟質ポリウレタンフォームが硬度分布を呈するメカニズムについて説明する。例えばクッション材として使用される軟質ポリウレタンフォームは、下型側が上面、上型側が下面となるようモールド内で成型される。このため軟質ポリウレタンフォームは、モールド内で上面が先に形成され、発泡による体積膨張の末、最終的に下面が形成される。上面側でフォームが形成される際には、糖質が水と会合することで、水とイソシアネートとの反応を遅延化し、高硬度のウレア結合の生成が抑制される。一方、高温反応で形成される芯層部から下面側においては、ウレア結合が集中して生成するため高硬度化し、硬度分布が発現すると考えられる。
[Mechanism by which flexible polyurethane foam exhibits hardness distribution]
The mechanism by which the flexible polyurethane foam according to the present invention exhibits a hardness distribution will be explained. For example, a soft polyurethane foam used as a cushioning material is molded in a mold so that the lower mold side is the upper surface and the upper mold side is the lower surface. For this reason, the upper surface of the flexible polyurethane foam is formed first in the mold, and after volume expansion due to foaming, the lower surface is finally formed. When foam is formed on the upper surface side, carbohydrates associate with water, which delays the reaction between water and isocyanate and suppresses the formation of highly hard urea bonds. On the other hand, on the lower surface side from the core layer formed by high-temperature reaction, urea bonds are concentrated and generated, resulting in high hardness and a hardness distribution.
以上のように製造された軟質ポリウレタンフォームは、硬さや、反発弾性率等の物性に優れるのみならず、上面側から下面側にかけて硬度が上昇する硬度分布を有することから、乗り心地性に優れたクッション材として提供することが可能となる。 The flexible polyurethane foam manufactured as described above not only has excellent physical properties such as hardness and rebound modulus, but also has a hardness distribution in which the hardness increases from the top side to the bottom side, so it has excellent ride comfort. It becomes possible to provide it as a cushioning material.
以下、実施例及び比較例に基づいて本発明をより具体的に説明するが、本発明は以下の実施例に限定されるものではない。なお、特に断りのない限り、文中の「部」、「%」は質量基準である。 EXAMPLES Hereinafter, the present invention will be described in more detail based on Examples and Comparative Examples, but the present invention is not limited to the following Examples. In addition, unless otherwise specified, "part" and "%" in the text are based on mass.
[ポリオール組成物の調製]
(実施例1~15、比較例1~6)
攪拌機、冷却管、窒素導入管、温度計を備えた反応器を窒素置換した後、ポリオール1を700g、ポリオール3を300g、ポリオール4を15g、架橋剤1を15g、架橋剤11を20g、触媒1を8.0g、触媒2を2.0g、整泡剤1を10g、水を36g仕込み、23℃にて0.5時間撹拌させることにより、ポリオール組成物(P-1)を得た。その他のポリオール組成物(P-2~P-21)もP-1と同様に調製した。
[Preparation of polyol composition]
(Examples 1 to 15, Comparative Examples 1 to 6)
After purging the reactor equipped with a stirrer, cooling tube, nitrogen inlet tube, and thermometer with nitrogen, add 700 g of polyol 1, 300 g of polyol 3, 15 g of polyol 4, 15 g of crosslinking agent 1, 20 g of crosslinking agent 11, and catalyst. A polyol composition (P-1) was obtained by charging 8.0 g of Catalyst 1, 2.0 g of Catalyst 2, 10 g of Foam Stabilizer 1, and 36 g of water and stirring at 23° C. for 0.5 hour. Other polyol compositions (P-2 to P-21) were also prepared in the same manner as P-1.
表1~4に示す原料のうち、ポリイソシアネート成分以外の全原料の混合物(ポリオール組成物)の液温を24℃~26℃に調整し、ポリイソシアネート成分を液温24℃~26℃に調整した。ポリオール組成物にポリイソシアネート成分を所定量加えて、ミキサー(毎分7000回転)で7秒間混合後、金型内に注入し軟質ポリウレタンフォームを発泡させた。その後、金型より取り出して、得られた軟質ポリウレタンフォームの物性を測定した。なお、表1~4におけるNCO Indexは、配合物中に存在する活性水素原子数に対するNCO基の比率である。 Among the raw materials shown in Tables 1 to 4, the liquid temperature of the mixture (polyol composition) of all raw materials other than the polyisocyanate component was adjusted to 24°C to 26°C, and the liquid temperature of the polyisocyanate component was adjusted to 24°C to 26°C. did. A predetermined amount of the polyisocyanate component was added to the polyol composition, mixed for 7 seconds using a mixer (7000 revolutions per minute), and then poured into a mold to foam a flexible polyurethane foam. Thereafter, it was taken out from the mold and the physical properties of the obtained flexible polyurethane foam were measured. Note that the NCO Index in Tables 1 to 4 is the ratio of NCO groups to the number of active hydrogen atoms present in the formulation.
[発泡条件]
金型温度:60~70℃
金型形状:300mm×300mm×100mm
金型材質:アルミニウム
キュア時間:5分
[Foaming conditions]
Mold temperature: 60-70℃
Mold shape: 300mm x 300mm x 100mm
Mold material: Aluminum Cure time: 5 minutes
[使用原料]
・ポリオール1:平均官能基数=3.0、水酸基価=24(mgKOH/g)、末端一級化率=84%、オキシエチレン単位=14.6質量%、総不飽和度0.03meq./gのポリオキシエチレンポリオキシプロピレンポリオール、東ソー社製NEF-693
・ポリオール2:平均官能基数=3.0、水酸基価=24(mgKOH/g)、末端一級化率=79%、オキシエチレン単位=14.0質量%、総不飽和度0.19meq./gのポリオキシエチレンポリオキシプロピレンポリオール、東ソー社製NEF-728
・ポリオール3:平均官能基数=3.0、水酸基価=24(mgKOH/g)のポリマーポリオール、AGC社製エクセノールEL-923
・ポリオール4:平均官能基数=3.0、水酸基価=24(mgKOH/g)、オキシエチレン単位が70質量%のポリエーテルポリオール、東ソー社製NEF-729
・ポリオール5:平均官能基数=4.0、水酸基価=28(mgKOH/g)、オキシエチレン単位が80質量%のポリオキシエチレンポリオキシプロピレンポリオール、東ソー社製NEF-024
・ポリオール6:平均官能基数=4.0、水酸基価=28(mgKOH/g)、オキシエチレン単位が90質量%のポリオキシエチレンポリオキシプロピレンポリオール、東ソー社製NEF-730
・架橋剤1:D-(+)-グルコース(富士フィルム和光純薬社製、単糖類)
・架橋剤2:D-(-)-フルクトース(東京化成工業社製、単糖類)
・架橋剤3:D-(+)-スクロース(東京化成工業社製、二糖類)
・架橋剤4:D-(+)-ラフィノース(東京化成工業社製、三糖類)
・架橋剤5:ブドウ糖果糖液糖(日本食品加工社製、単糖類から十糖類の混合物)
・架橋剤6:γ―シクロデキストリン(東京化成工業社製、八糖類)
・架橋剤7:マルトースシラップ(日本食品加工社製、単糖類から十糖類の混合物)
・架橋剤8:精製グリセリン(阪本薬品工業社製)
・架橋剤9:トリメチロールプロパン(三菱ガス化学社製)
・架橋剤10:ジエタノールアミン(三井化学社製)
・架橋剤11:PEG200(三洋化成工業社製、ポリエチレングリコール、数平均分子量200)
・架橋剤12:CHDM―D(1,4-シクロヘキサンジメタノール、EASTMAN CHEMICAL社製、脂環族グリコール)
・触媒1:2-ヒドロキシメチルトリエチレンジアミン(東ソー社製、商品名:R-ZETA HD)
・触媒2:N、N、N’-トリメチル-N’-ヒドロキシエチル-ビスアミノエチルエーテル(東ソー社製、商品名:TOYOCAT RX-10)
・整泡剤1:シリコーン系整泡剤(エボニック社製、商品名:B-8715LF2)
・イソシアネート1:MDI含有率85質量%、アイソマー含有率38質量%のポリフェニレンポリメチレンポリイソシアネート(東ソー社製、商品名:CEF-550)。
[Raw materials used]
- Polyol 1: average number of functional groups = 3.0, hydroxyl value = 24 (mgKOH/g), terminal primaryization rate = 84%, oxyethylene unit = 14.6% by mass, total unsaturation degree 0.03 meq. /g of polyoxyethylene polyoxypropylene polyol, manufactured by Tosoh Corporation NEF-693
- Polyol 2: average number of functional groups = 3.0, hydroxyl value = 24 (mgKOH/g), terminal primaryization rate = 79%, oxyethylene unit = 14.0% by mass, total degree of unsaturation 0.19 meq. /g of polyoxyethylene polyoxypropylene polyol, NEF-728 manufactured by Tosoh Corporation
・Polyol 3: Polymer polyol with average functional group number = 3.0 and hydroxyl value = 24 (mgKOH/g), Excenol EL-923 manufactured by AGC
・Polyol 4: average number of functional groups = 3.0, hydroxyl value = 24 (mgKOH/g), polyether polyol with 70% by mass of oxyethylene units, NEF-729 manufactured by Tosoh Corporation
・Polyol 5: average number of functional groups = 4.0, hydroxyl value = 28 (mgKOH/g), polyoxyethylene polyoxypropylene polyol with oxyethylene units of 80% by mass, NEF-024 manufactured by Tosoh Corporation
・Polyol 6: average number of functional groups = 4.0, hydroxyl value = 28 (mgKOH/g), polyoxyethylene polyoxypropylene polyol with oxyethylene units of 90% by mass, NEF-730 manufactured by Tosoh Corporation
・Crosslinking agent 1: D-(+)-glucose (manufactured by Fuji Film Wako Pure Chemical Industries, Ltd., monosaccharide)
・Crosslinking agent 2: D-(-)-fructose (manufactured by Tokyo Kasei Kogyo Co., Ltd., monosaccharide)
・Crosslinking agent 3: D-(+)-sucrose (manufactured by Tokyo Kasei Kogyo Co., Ltd., disaccharide)
・Crosslinking agent 4: D-(+)-raffinose (manufactured by Tokyo Kasei Kogyo Co., Ltd., trisaccharide)
・Crosslinking agent 5: Glucose fructose liquid sugar (manufactured by Nippon Shokuhin Kogyo Co., Ltd., a mixture of monosaccharides and decasaccharides)
・Crosslinking agent 6: γ-cyclodextrin (manufactured by Tokyo Kasei Kogyo Co., Ltd., octasaccharide)
・Crosslinking agent 7: Maltose syrup (manufactured by Nihon Shokuhin Kogyo Co., Ltd., a mixture of monosaccharides and decasaccharides)
・Crosslinking agent 8: Purified glycerin (manufactured by Sakamoto Pharmaceutical Co., Ltd.)
・Crosslinking agent 9: Trimethylolpropane (manufactured by Mitsubishi Gas Chemical Co., Ltd.)
・Crosslinking agent 10: Diethanolamine (manufactured by Mitsui Chemicals)
・Crosslinking agent 11: PEG200 (manufactured by Sanyo Chemical Industries, polyethylene glycol, number average molecular weight 200)
・Crosslinking agent 12: CHDM-D (1,4-cyclohexanedimethanol, manufactured by EASTMAN CHEMICAL, alicyclic glycol)
・Catalyst 1: 2-hydroxymethyltriethylenediamine (manufactured by Tosoh Corporation, product name: R-ZETA HD)
・Catalyst 2: N,N,N'-trimethyl-N'-hydroxyethyl-bisaminoethyl ether (manufactured by Tosoh Corporation, product name: TOYOCAT RX-10)
・Foam stabilizer 1: Silicone foam stabilizer (manufactured by Evonik, product name: B-8715LF2)
- Isocyanate 1: Polyphenylene polymethylene polyisocyanate with an MDI content of 85% by mass and an isomer content of 38% by mass (manufactured by Tosoh Corporation, trade name: CEF-550).
[成形性評価]
各表中、成形性「○」の評価は、ウレタンフォームが最高の高さに達した後に大きく沈んでいく崩壊や、生成したウレタンフォームが発泡直後またはキュア後に収縮する現象が生じることなく、軟質ポリウレタンフォームが成形できたことを意味し、「×」の評価は、ウレタンフォームに崩壊、収縮等の現象が生じた事を意味する。
[Moldability evaluation]
In each table, the evaluation of formability "○" means that the urethane foam does not collapse after reaching its maximum height, or the generated urethane foam shrinks immediately after foaming or after curing, and is soft. It means that the polyurethane foam was molded, and an evaluation of "x" means that phenomena such as collapse and shrinkage occurred in the urethane foam.
[見掛け密度]
JIS K6400記載の方法により求めた。
[Apparent density]
It was determined by the method described in JIS K6400.
[スキン付き試験片フォームの25%圧縮硬さ(25%ILD)]
JIS K6400記載のB法により求めた。
[25% compression hardness (25% ILD) of skinned specimen foam]
It was determined by method B described in JIS K6400.
[反発弾性率]
JIS K6400記載の方法で測定した。
[Repulsion modulus]
It was measured by the method described in JIS K6400.
[湿熱圧縮歪み]
JIS K6400記載の方法で測定した。
[Moist heat compression strain]
It was measured by the method described in JIS K6400.
[伸び率]
JIS K6400記載の方法で測定した。
[Growth rate]
It was measured by the method described in JIS K6400.
[軟質ポリウレタンフォームの発泡高さ方向における硬度分布について]
本発明における硬度分布測定用サンプルは、100mmの厚みで上型側が下面、下型側が上面となるようにモールド成型された軟質ポリウレタンフォームを、上面側の端面から下面側に向かって45mm毎に切り出した2層のフォーム「上面側:0mm(上面端)~45.0mm、下面側:45.0mm~90.0mm」とする。
前記した2層の評価サンプルそれぞれについて、まず、加圧板を加圧板の受ける応力が0.98Nになるまで評価サンプルを圧縮し、この位置を評価サンプルの厚みが100%である加圧板の初期位置とする。加圧板は直径200mmの円盤とする。次に、加圧板を評価サンプルに向けて50mm/minの速さで、評価サンプルの厚みの25%まで圧縮させる。その後、加圧板を50mm/minの速さで初期位置に復帰させる。以上の過程において、評価サンプルが25%圧縮変形した時に、評価サンプルに及ぼされた応力値を測定し、この値を25%圧縮硬度とした。
[About hardness distribution in the foaming height direction of flexible polyurethane foam]
The samples for hardness distribution measurement in the present invention are made by cutting a flexible polyurethane foam with a thickness of 100 mm, which is molded so that the upper mold side is the lower surface and the lower mold side is the upper surface, every 45 mm from the end surface of the upper surface side toward the lower surface side. The foam has two layers: "Top side: 0 mm (top edge) to 45.0 mm, bottom side: 45.0 mm to 90.0 mm".
For each of the two layers of evaluation samples described above, first compress the evaluation sample until the stress applied to the pressure plate becomes 0.98N, and this position is set as the initial position of the pressure plate where the thickness of the evaluation sample is 100%. shall be. The pressure plate is a disk with a diameter of 200 mm. Next, the pressure plate is directed toward the evaluation sample and compressed to 25% of the thickness of the evaluation sample at a speed of 50 mm/min. Thereafter, the pressure plate is returned to the initial position at a speed of 50 mm/min. In the above process, when the evaluation sample was compressively deformed by 25%, the stress value applied to the evaluation sample was measured, and this value was defined as the 25% compression hardness.
そして、2層それぞれの評価サンプルの25%圧縮硬度の平均値を100とした際の各評価サンプルの硬度の比を算出した。つまりこの硬度比は、発泡高さ方向の平均的な硬度に対する各評価サンプルの硬度比を意味する。
2層それぞれの評価サンプルの25%圧縮硬度の平均値を100とした際の、上面側フォームの硬度比が、50~85%であれば、硬度分布を有すると言える。
Then, the hardness ratio of each evaluation sample was calculated when the average value of the 25% compression hardness of the evaluation samples of each of the two layers was set as 100. In other words, this hardness ratio means the hardness ratio of each evaluation sample to the average hardness in the foaming height direction.
If the hardness ratio of the upper foam is 50 to 85% when the average value of the 25% compression hardness of the evaluation samples of the two layers is 100, it can be said that the foam has a hardness distribution.
[ウレア結合比の算出方法]
上記2層の評価サンプルについてFT-IR測定を行い、波数1660cm-1付近に観測されるウレア結合由来のピーク高さを波数1710cm-1付近に観測されるウレタン結合由来のピーク高さで割ることでウレア結合比を算出した。つまりこのウレア結合比が小さい程、ウレア結合の生成が抑制され、硬度が発現しにくいことを意味する。
[Calculation method of urea bond ratio]
Perform FT-IR measurement on the evaluation sample of the above two layers, and divide the peak height derived from urea bond observed around wave number 1660 cm -1 by the peak height derived from urethane bond observed around wave number 1710 cm -1 . The urea bond ratio was calculated. In other words, the smaller the urea bond ratio is, the more suppressed the formation of urea bonds is, and the harder it is to develop hardness.
[軟質ポリウレタンフォームのセルの異方性(形状)]
本発明におけるセル異方性の測定サンプルは、100mmの厚みでモールド成型された軟質ポリウレタンフォームにおいて、上面側の端面から下面側に向かって22.5mm毎に切り出した4層のフォーム「1層目:0mm(上面端)~22.5mm、2層目:22.5mm~45mm、3層目:45mm~67.5mm、4層目:67.5mm~90mm」とする。上記1層目~4層目まで4層に分割した。得られた各層を垂直方向に2等分し、その断面の中心部分(視野:3.2mm×3.2mm)の拡大画像をマイクロスコープ顕微鏡により取得した。取得した画像を下から上に向かって発泡方向となるように見た際に、画像の中から発泡セルをランダムに30個選択して、発泡方向のセル長と発泡方向に直行するセル長を測定した。セル毎に発泡方向のセル長を発泡方向に直行するセル長で割った値を求め、セル30個の平均値をセル異方性の評価値として用いた。異方性の数値が1に近い程セル形状が球状に近づき、数値が小さい程発泡方向に対して横長、数値が大きい程発泡方向に対して縦長であることを意味する。本実施例においては、実施例1、比較例3を代表例として測定した。
[Cell anisotropy (shape) of flexible polyurethane foam]
The sample for measuring cell anisotropy in the present invention was a flexible polyurethane foam molded with a thickness of 100 mm, and four layers of foam were cut out every 22.5 mm from the upper end surface toward the lower surface. : 0 mm (top edge) to 22.5 mm, 2nd layer: 22.5 mm to 45 mm, 3rd layer: 45 mm to 67.5 mm, 4th layer: 67.5 mm to 90 mm. It was divided into four layers from the first layer to the fourth layer. Each of the obtained layers was vertically divided into two equal parts, and an enlarged image of the central portion of the cross section (field of view: 3.2 mm x 3.2 mm) was obtained using a microscope. When the acquired image is viewed from bottom to top in the foaming direction, 30 foamed cells are randomly selected from the image and the cell length in the foaming direction and the cell length perpendicular to the foaming direction are calculated. It was measured. A value obtained by dividing the cell length in the foaming direction by the cell length perpendicular to the foaming direction was determined for each cell, and the average value of 30 cells was used as the evaluation value of cell anisotropy. The closer the anisotropy value is to 1, the more spherical the cell shape, the smaller the value, the more horizontally elongated with respect to the foaming direction, and the larger the value, the more vertically elongated with respect to the foaming direction. In this example, measurements were made using Example 1 and Comparative Example 3 as representative examples.
表4の比較例1~5に示すように、架橋剤として糖質(E-1)を使用しない場合には、硬度分布の発現は極めて小さい、もしくは発現しない。これらの場合には、実施例と比較して上面側でのウレア結合比が高く、下面側でのウレア結合比が低い。また、セル異方性と硬度分布比には相関性が無いことから、セル異方性の制御により硬度分布が発現しているとは言えない。比較例6に示すように、架橋剤として糖質(E-1)を使用した場合でも、規定量に対して使用量が多すぎる場合にはフォームの成型安定性が著しく低下し、フォームを成型することができない。以上の実施例及び比較例を対比することにより、本発明においては、例えばクッション材として用いたときの座り心地が良好な硬度分布を有し、好ましい物性を有する成型体が得られることは明確であり、本発明の構成の有意性と顕著な卓越性を理解できる。 As shown in Comparative Examples 1 to 5 in Table 4, when carbohydrate (E-1) is not used as a crosslinking agent, the hardness distribution is extremely small or does not appear. In these cases, the urea bonding ratio on the upper surface side is higher and the urea bonding ratio on the lower surface side is lower than in the example. Furthermore, since there is no correlation between cell anisotropy and hardness distribution ratio, it cannot be said that hardness distribution is expressed by controlling cell anisotropy. As shown in Comparative Example 6, even when carbohydrate (E-1) is used as a crosslinking agent, if the amount used is too large compared to the specified amount, the molding stability of the foam decreases significantly, making it difficult to mold the foam. Can not do it. By comparing the above Examples and Comparative Examples, it is clear that in the present invention, a molded article having a hardness distribution that provides good sitting comfort when used as a cushioning material, and has favorable physical properties can be obtained. Therefore, the significance and remarkable excellence of the structure of the present invention can be understood.
Claims (18)
前記架橋剤(E)として糖質(E-1)を含有し、該糖質(E-1)の添加量がポリオール成分(A)に対して0.1~5質量%であり、
前記糖質(E-1)の平均糖鎖数が1.0以上9.0以下であり、
前記水(D)の添加量が、前記ポリオール成分(A)に対して3.0~10質量%であることを特徴とする、軟質ポリウレタンフォーム成型用ポリオール組成物。 A polyol composition for molding flexible polyurethane foam, comprising a polyol component (A), a catalyst (B), a foam stabilizer (C), water (D), and a crosslinking agent (E),
A carbohydrate (E-1) is contained as the crosslinking agent (E), and the amount of the carbohydrate (E-1) added is 0.1 to 5% by mass relative to the polyol component (A),
The average number of sugar chains of the carbohydrate (E-1) is 1.0 or more and 9.0 or less,
A polyol composition for molding flexible polyurethane foam, characterized in that the amount of water (D) added is 3.0 to 10% by mass based on the polyol component (A).
前記架橋剤(E)として糖質(E-1)を含有し、該糖質(E-1)の添加量がポリオール成分(A)に対して0.1~5質量%であり、A carbohydrate (E-1) is contained as the crosslinking agent (E), and the amount of the carbohydrate (E-1) added is 0.1 to 5% by mass based on the polyol component (A),
前記水(D)の添加量が、前記ポリオール成分(A)に対して3.0~10質量%であり、The amount of water (D) added is 3.0 to 10% by mass based on the polyol component (A),
着座面を有するクッション用であることを特徴とする、軟質ポリウレタンフォーム成型用ポリオール組成物。A polyol composition for molding a flexible polyurethane foam, which is used for a cushion having a seating surface.
該ポリエーテルポリオールの数平均分子量が、4,000~8,000であり、
前記ポリエーテルポリオールの添加量が、前記ポリオール成分(A)に対して0.5~5質量%であることを特徴とする、請求項1乃至6のいずれかに記載の軟質ポリウレタンフォーム成型用ポリオール組成物。 The polyol component (A) contains a polyether polyol having a polyoxyalkylene chain consisting of a copolymer of oxyethylene and oxypropylene and having an oxyethylene unit of 60 to 90% by mass,
The number average molecular weight of the polyether polyol is 4,000 to 8,000,
The polyol for molding flexible polyurethane foam according to any one of claims 1 to 6 , wherein the amount of the polyether polyol added is 0.5 to 5% by mass based on the polyol component (A). Composition.
前記軟質ポリウレタンフォーム成型用ポリオール組成物が、ポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、及び架橋剤(E)を含み、
前記架橋剤(E)として糖質(E-1)を含有し、該糖質(E-1)の添加量がポリオール成分(A)に対して0.1~5質量%であり、
前記糖質(E-1)の平均糖鎖数が1.0以上9.0以下であり、
上型側が下面、下型側が上面となるようにモールド成型された軟質ポリウレタンフォームを、上面側の端面から下面側に向かって厚みの45%毎に切り出した2層のフォームにおいて、2層それぞれのフォームの25%圧縮硬度の平均値を100とした際の上面側フォームの硬度比が50~85%であり、
反発弾性率が45~75%であることを特徴とする、軟質ポリウレタンフォーム。 A flexible polyurethane foam obtained by reaction-foaming a flexible polyurethane foam-molding composition containing a flexible polyurethane foam-molding polyol composition and a polyisocyanate component (F),
The polyol composition for molding flexible polyurethane foam includes a polyol component (A), a catalyst (B), a foam stabilizer (C), a blowing agent (D), and a crosslinking agent (E),
A carbohydrate (E-1) is contained as the crosslinking agent (E), and the amount of the carbohydrate (E-1) added is 0.1 to 5% by mass relative to the polyol component (A),
The average number of sugar chains of the carbohydrate (E-1) is 1.0 or more and 9.0 or less,
Two layers of soft polyurethane foam were cut out at 45% thickness intervals from the upper end to the lower end, which were molded so that the upper mold side was the lower surface and the lower mold side was the upper surface. The hardness ratio of the upper foam is 50 to 85% when the average value of the 25% compression hardness of the foam is 100,
A flexible polyurethane foam characterized by a rebound modulus of 45 to 75%.
前記軟質ポリウレタンフォーム成型用ポリオール組成物が、ポリオール成分(A)、触媒(B)、整泡剤(C)、発泡剤(D)、及び架橋剤(E)を含み、The polyol composition for molding flexible polyurethane foam includes a polyol component (A), a catalyst (B), a foam stabilizer (C), a blowing agent (D), and a crosslinking agent (E),
前記架橋剤(E)として糖質(E-1)を含有し、該糖質(E-1)の添加量がポリオール成分(A)に対して0.1~5質量%であり、A carbohydrate (E-1) is contained as the crosslinking agent (E), and the amount of the carbohydrate (E-1) added is 0.1 to 5% by mass relative to the polyol component (A),
上型側が下面、下型側が上面となるようにモールド成型された軟質ポリウレタンフォームを、上面側の端面から下面側に向かって厚みの45%毎に切り出した2層のフォームにおいて、2層それぞれのフォームの25%圧縮硬度の平均値を100とした際の上面側フォームの硬度比が50~85%であり、Two layers of soft polyurethane foam were cut out at 45% thickness intervals from the upper end to the lower end, which were molded so that the upper mold side was the lower surface and the lower mold side was the upper surface. The hardness ratio of the upper foam is 50 to 85% when the average value of the 25% compression hardness of the foam is 100,
反発弾性率が45~75%であり、The rebound modulus is 45 to 75%,
見掛け密度が30~70kg/mApparent density is 30-70kg/m 33 であることを特徴とする、軟質ポリウレタンフォーム。A flexible polyurethane foam characterized by:
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2019/048707 WO2020129806A1 (en) | 2018-12-21 | 2019-12-12 | Polyol composition for molding flexible polyurethane foam |
JP2024012737A JP2024032914A (en) | 2018-12-21 | 2024-01-31 | Polyol composition for molding flexible polyurethane foam |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018239669 | 2018-12-21 | ||
JP2018239669 | 2018-12-21 | ||
JP2019027120 | 2019-02-19 | ||
JP2019027120 | 2019-02-19 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024012737A Division JP2024032914A (en) | 2018-12-21 | 2024-01-31 | Polyol composition for molding flexible polyurethane foam |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020128519A JP2020128519A (en) | 2020-08-27 |
JP7443696B2 true JP7443696B2 (en) | 2024-03-06 |
Family
ID=72175266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019156884A Active JP7443696B2 (en) | 2018-12-21 | 2019-08-29 | Polyol composition for molding flexible polyurethane foam |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7443696B2 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001106780A (en) | 1998-10-20 | 2001-04-17 | Mitsui Chemicals Inc | Method for producing polyoxyalkylene polyol and its derivative |
JP2002030129A (en) | 2000-02-17 | 2002-01-31 | Mitsui Chemicals Inc | Slightly foamed polyurethane elastomer and its manufacturing method |
JP2008500417A (en) | 2004-05-26 | 2008-01-10 | ダニスコ エイ/エス | Polyurethanes containing polyol compositions comprising highly branched polysaccharides, mixtures and methods for making them. |
JP2012102156A (en) | 2010-11-05 | 2012-05-31 | Tosoh Corp | Method of manufacturing flexible polyurethane foam |
WO2013021871A1 (en) | 2011-08-05 | 2013-02-14 | 旭硝子株式会社 | Manufacturing method for soft polyurethane foam |
WO2016017628A1 (en) | 2014-07-28 | 2016-02-04 | 東ソー株式会社 | Polyisocyanate composition for producing flexible polyurethane foam, and flexible polyurethane foam production method using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811829A (en) * | 1995-08-10 | 1998-09-22 | Arco Chemical Technology, L.P. | Viscosity stable isocyanate-terminated prepolymers and polyoxyalkylene polyether polyols having improved storage stability |
-
2019
- 2019-08-29 JP JP2019156884A patent/JP7443696B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001106780A (en) | 1998-10-20 | 2001-04-17 | Mitsui Chemicals Inc | Method for producing polyoxyalkylene polyol and its derivative |
JP2002030129A (en) | 2000-02-17 | 2002-01-31 | Mitsui Chemicals Inc | Slightly foamed polyurethane elastomer and its manufacturing method |
JP2008500417A (en) | 2004-05-26 | 2008-01-10 | ダニスコ エイ/エス | Polyurethanes containing polyol compositions comprising highly branched polysaccharides, mixtures and methods for making them. |
JP2012102156A (en) | 2010-11-05 | 2012-05-31 | Tosoh Corp | Method of manufacturing flexible polyurethane foam |
WO2013021871A1 (en) | 2011-08-05 | 2013-02-14 | 旭硝子株式会社 | Manufacturing method for soft polyurethane foam |
WO2016017628A1 (en) | 2014-07-28 | 2016-02-04 | 東ソー株式会社 | Polyisocyanate composition for producing flexible polyurethane foam, and flexible polyurethane foam production method using same |
Also Published As
Publication number | Publication date |
---|---|
JP2020128519A (en) | 2020-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2024032914A (en) | Polyol composition for molding flexible polyurethane foam | |
JP5964879B2 (en) | Cellular structure and viscoelastic polyurethane foam | |
CN1939948B (en) | Silanol-functionalized compounds for the preparation of polyurethane foams | |
EP2029651B1 (en) | A process for the production of rigid and semi-rigid foams with low amounts of diisocyanate using polymer polyols characterized by high solids and a high hydroxyl number and the resultant foams | |
KR101364368B1 (en) | Process for producing viscoelastic polyurethane foams | |
JP2022531170A (en) | Rigid polyurethane foam suitable for use as panel insulation | |
EP3935097B1 (en) | Polyol blends and their use in producing pur-pir foam-forming compositions | |
WO2006057255A1 (en) | Soft polyurethane foam, process for producing the same and automobile seat | |
JP2022523800A (en) | HSFO-containing isocyanate-reactive compositions, related foam-forming compositions, and PUR-PIR foams. | |
JP2017165985A (en) | Method for preparing flexible polyurethane foam with hydrolyzable silane compounds | |
JP7204650B2 (en) | Polyol blends useful for making viscoelastic foams | |
JP7443696B2 (en) | Polyol composition for molding flexible polyurethane foam | |
JP3992869B2 (en) | Energy-absorbing flexible polyurethane foam and method for producing the same | |
US9193821B2 (en) | Process for producing viscoelastic flexible polyurethane foams | |
JP7148018B2 (en) | Polyol composition for forming flexible polyurethane foam, composition for forming flexible polyurethane foam, flexible polyurethane foam and method for producing the same | |
WO2018235515A1 (en) | Composition for soft polyurethane foam, soft polyurethane foam, and vehicle seat pad | |
CN115698114A (en) | Viscoelastic elastomer polyurethane foam, method for the production thereof and use thereof | |
JP5895685B2 (en) | Method for producing polyurethane foam using polyoxyalkylene polyol | |
WO2024064181A1 (en) | Rigid polyurethane foam | |
JP5732845B2 (en) | Catalyst composition for producing flexible polyurethane foam, and method for producing flexible polyurethane foam using the same | |
JP5869936B2 (en) | Polyurethane foam for seat pads | |
JP2003040966A (en) | Soft polyurethane foam | |
MX2008006670A (en) | Process for producing viscoelastic polyurethane foams |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220714 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230314 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230510 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230713 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230801 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230801 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230905 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231031 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231226 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240123 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240205 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 7443696 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |